Hooray, finally women have realsied that facelifts are not the answer to looking good. Often they end up with a botched up job and look worse than they did beforre.
Death of the facelift: women shun plastic surgery in favour of more subtle cosmetic help
Experts said the overall decline in “nip and tuck” surgery comes amid
the rise of less invasive treatment. None the less, some procedures
remain on the rise.
The number of women having breast enlargement - the most popular
procedure of all - rose by 7 per cent. The figures from the British
Association of Aesthetic Plastic Surgeons (Baaps) show 8,328 such cases
in 2017.
But almost as great an increase was seen in breast reduction surgery,
with a five per cent rise in such operations, among women who regretted
previous decisions. In total, 3,747 such operations were carried out.
There
were 28,315 cosmetic surgery procedures carried out in total in 2017,
the audit shows - a drop of eight per cent in one year. Nine of out ten
operations were on women.
Meanwhile, men appeared to turn their backs on “short cuts” to the
body beautiful, with liposuction down 20 per cent, tummy tucks down 12
per cent and a 7 per cent drop in procedures to tackle “man boobs”.
TV
presenter Anne Robinson has admitted she had a facelift in 2003, while
Simon Cowell, Joanna Lumley and Courtney Cox have all been open about
having had less invasive surgery such as fillers and botox.
BAAPS President and consultant plastic surgeon Simon Withey said some
were turning away from cosmetic surgery because they thought more about
the serious impact of the procedures - while others were turning to
non-surgical options, such as botox and fillers.
“The slight downwards shift in surgical procedures overall hopefully
continues to demonstrate that at the very least, patients are realising
that cosmetic surgery is not a ‘quick fix’ but a serious commitment,” he
said.
“Although there may be some new non-surgical options
for cosmetic treatments, it is important to remember that ‘non-surgical’
does not mean ‘non-medical’, and patients should be wary of anything
touted which seems too good, or too cheap, to be true. The climate of
lax regulation has yet to be addressed in a satisfactory manner to
protect the public.”
Newswise — Many know Botox as a trendy way to get rid of wrinkles,
but the popular drug — made from botulinum neurotoxin (BoNT) — can do
more than just fill lines.
Many may not realize that BoNT is one
of the most potent biological toxins known to man. Just one small dose
injected intravenously could easily paralyze and kill a human being.
However, in a controlled dose and purified form, the toxin can be used
for therapeutic purposes, helping treat a variety of diseases.
Currently,
BoNT is being used for the treatment of neck spasms (cervical
dystonia), eyelid spasms (blepharospasms), crossed eyes (strabismus),
severe underarm sweating (hyperhidrosis), migraines and other primary
headaches, depression — and is even being used with cancer therapies.
This article struck me as one of interest to those who are thinking of having Botox but also who have had this:
A study co-led by Rongsheng Jin,
professor of physiology & biophysics at the University of
California, Irvine; Min Dong with Boston Children’s Hospital-Harvard
Medical School; and Andreas Rummel with the Hannover Medical School in
Germany, reveals an important general mechanism by which the pathogen is
attracted to, adapts to and takes advantage of glycan modifications in
surface receptors to invade motor neurons. Glycans are chains of sugars
synthesized by cells for their development, growth, functioning or
survival. Results appear June 13 in Nature Structural and Molecular
Biology.
